Killing	O
tumor	B-Cell
cells	I-Cell
through	O
their	O
surface	B-Cellular_component
beta	O
(	O
2	O
)	O
-	O
microglobulin	O
or	O
major	O
histocompatibility	O
complex	O
class	O
I	O
molecules	O
.	O

Targeted	O
antibody	O
-	O
based	O
therapy	O
has	O
been	O
used	O
successfully	O
to	O
treat	O
cancers	B-Cancer
.	O

Recent	O
studies	O
have	O
demonstrated	O
that	O
tumor	B-Cell
cells	I-Cell
treated	O
with	O
antibodies	O
specific	O
for	O
beta	O
(	O
2	O
)	O
-	O
microglobulin	O
(	O
beta	O
(	O
2	O
)	O
M	O
)	O
or	O
major	O
histocompatibility	O
complex	O
(	O
MHC	O
)	O
class	O
I	O
molecules	O
undergo	O
apoptosis	O
in	O
vitro	O
and	O
in	O
vivo	O
(	O
mouse	O
models	O
)	O
.	O

Antibodies	O
against	O
beta	O
(	O
2	O
)	O
M	O
or	O
MHC	O
class	O
I	O
induce	O
tumor	B-Cell
cell	I-Cell
apoptosis	O
by	O
1	O
)	O
recruiting	O
MHC	O
class	O
I	O
molecules	O
to	O
lipid	B-Organism_substance
rafts	I-Organism_substance
and	O
activating	O
LYN	O
kinase	O
and	O
the	O
signal	O
-	O
transducing	O
enzyme	O
phospholipase	O
C	O
-	O
gamma2	O
-	O
dependent	O
c	O
-	O
Jun	O
N	O
-	O
terminal	O
kinase	O
signaling	O
pathway	O
and	O
2	O
)	O
expelling	O
interleukin	O
6	O
and	O
insulin	O
-	O
like	O
growth	O
factor	O
1	O
receptors	O
out	O
of	O
lipid	B-Organism_substance
rafts	I-Organism_substance
and	O
inhibiting	O
the	O
growth	O
and	O
survival	O
factor	O
-	O
induced	O
activation	O
of	O
the	O
phosphatidylinositol	O
3	O
-	O
kinase	O
/	O
Akt	O
and	O
extracellular	O
signal	O
-	O
related	O
kinase	O
pathways	O
.	O

Consequently	O
,	O
mitochondrial	B-Cellular_component
integrity	O
is	O
compromised	O
,	O
and	O
the	O
caspase	O
-	O
9	O
-	O
dependent	O
cascade	O
is	O
activated	O
in	O
treated	O
tumor	B-Cell
cells	I-Cell
.	O

However	O
,	O
although	O
beta	O
(	O
2	O
)	O
M	O
and	O
MHC	O
class	O
I	O
are	O
expressed	O
on	O
normal	O
hematopoietic	B-Cell
cells	I-Cell
,	O
which	O
is	O
a	O
potential	O
safety	O
concern	O
,	O
the	O
monoclonal	O
antibodies	O
were	O
selective	O
to	O
tumor	B-Cell
cells	I-Cell
and	O
did	O
not	O
damage	O
normal	O
cells	B-Cell
in	O
vitro	O
or	O
in	O
human	O
-	O
like	O
mouse	O
models	O
.	O

These	O
findings	O
suggest	O
that	O
targeting	O
beta	O
(	O
2	O
)	O
M	O
or	O
MHC	O
class	O
I	O
by	O
using	O
antibodies	O
or	O
other	O
agents	O
offers	O
a	O
potential	O
therapeutic	O
approach	O
for	O
beta	O
(	O
2	O
)	O
M	O
/	O
MHC	O
class	O
I	O
-	O
expressing	O
malignancies	B-Cancer
.	O

Cancer	O
2010	O
.	O

(	O
c	O
)	O
2010	O
American	O
Cancer	O
Society	O
.	O

